Le Lézard
Classified in: Health, Covid-19 virus
Subjects: NPT, CHI, PDT, DIS

Kessler Foundation Launches Center for Autism Research


EAST HANOVER, N.J., April 13, 2022 /PRNewswire/ -- Kessler Foundation announces the opening of the Center for Autism Research, which is dedicated to developing evidence-based research for children, adolescents, and adults on the autism spectrum.

This new facility's focus is to improve quality of life for neurodiverse individuals who communicate, interact, behave, and learn differently than neurotypical people. The Center will explore outcomes and develop interventions for adults and children on the spectrum, with particular focus on the critical transition from adolescence to adulthood. 

Helen Genova, PhD, neuroscientist and associate director, is leading the newly formed team. Dr. Genova is known for her research in disorders of social functioning in populations with autism, brain injury and multiple sclerosis, with broad-based funding from federal, state, and private sources.

"Today marks a turning point in autism spectrum disorder research," said Rodger DeRose, president and CEO of Kessler Foundation. "With the support of our donors and the work of our scientists and collaborators, we are confident that our Center for Autism Research will deliver much needed behavioral breakthroughs to the autism community," he said.

The Center directly involves the autism community in multiple aspects of research, ensuring that the science is informed by those who matter the most. "By engaging the autism community, the Center will objectively deliver meaningful and accessible results to clinicians, educators, parents, and individuals on the autism spectrum," added DeRose.

"By exploring the complexities of autism, our Center will become a leading force in achieving new gains for individuals on the spectrum," stated DeRose.

"Our goal is to develop easily accessible tools for individuals on the spectrum to overcome barriers they face in community integration and social functioning. To address these issues, we are implementing principles of positive psychology, virtual reality technology, web-based interventions, and neuroimaging," explained Dr. Genova.

Historically, research and treatments have focused on deficits in the lives of individuals on the autism spectrum and attempts to control their problematic behaviors. "To reverse that negative pattern, we are using a strength-based, rather than a deficit- or pathology-based approach, to evaluate how young adults with and without autism identify and express their personal identities," added Dr. Genova.

Research in autism has been underway for more than a year at the Foundation, where Dr. Genova's team has worked on numerous studies, instituting a range of techniques and groundbreaking tools.

"We've established the novel Kessler Foundation Strength Identification and Expression (KF-STRIDE®), a web-based training tool to help young adults on the autism spectrum understand their strengths and how to convey them on job interviews. The intervention's goal is to improve the likelihood that transition-age youth on the autism spectrum will secure employment," said Dr. Genova.

In addition, the team conducted a survey during the COVID-19 pandemic discovering more negative consequences and markedly different stressors for children with autism compared to neurotypical children. And in collaboration with the Rocco Ortenzio Center for Neuroimaging at Kessler Foundation, Dr. Genova's team evaluates the relationship between brain function and how traits of autism are expressed.

The new Center is located at 120 Eagle Rock Ave., East Hanover, NJ, which has meeting rooms, testing facilities, and a new pediatric waiting room designed for the comfort of children and their parents. For information on research studies, email [email protected].

About Kessler Foundation

Kessler Foundation, a major nonprofit organization in the field of disability, is a global leader in rehabilitation research that seeks to improve cognition, mobility, and long-term outcomes -- including employment -- for people with neurological disabilities caused by diseases and injuries of the brain and spinal cord. Kessler Foundation leads the nation in funding innovative programs that expand opportunities for employment for people with disabilities. For more information, visit KesslerFoundation.org 

Stay Connected with Kessler Foundation

Twitter | Facebook | YouTube | Instagram | iTunes & SoundCloud

SOURCE Kessler Foundation


These press releases may also interest you

at 16:10
bluebird bio, Inc. today announced that it received a notice (the "notice") on April 24, 2024 from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company has not yet filed its Annual Report on Form 10-K for the year ended December...

at 16:10
Repare Therapeutics Inc. ("Repare" or the "Company") , a leading clinical-stage precision oncology company, today announced the appointment of Steven H. Stein, M.D., to its Board of Directors, effective as of the date of the Company's upcoming annual...

at 16:00
This program will support individuals in Putnam County with Opioid Use Disorder and co-occurring substance use and mental health conditions through peer support and harm reduction for the broader Putnam County community. A...

at 15:49
Life Time continues its growth in Texas with two new athletic country clubs opening in the coming months. Located in Irving, Life Time Las Colinas opens April 26. Later this summer, the nearby Life Time Westlake will debut. A waitlist is now open....

at 15:44
Grossman Law Offices, with its principal office in Dallas, TX, expresses concern and support for Eric Elliott and his family following a truck accident that occurred on February 20, 2024, just before 4:45 p.m. along U.S. Highway 67 in Johnson County,...

at 15:23
Boehringer Ingelheim, the largest animal health company in Georgia and its NexGard® PLUS (afoxolaner, moxidectin, and pyrantel chewable tablets) product, and the Atlanta Braves Foundation, the non-profit arm of the Atlanta Braves, are proud to...



News published on and distributed by: